Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIBUTE: Trimbow vs Ultibro in COPD
NCT02579850Phase 3Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- May 2015
- Primary completion
- Jul 2017
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of beclometasone dipropionate/formoterol fumarate/glycopyrronium in chronic obstructive pulmonary disease (COPD), sponsored by Chiesi Farmaceutici S.p.A.. Started May 2015; status: completed.
02
Drugs
beclometasone dipropionate/formoterol fumarate/glycopyrronium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02579850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02579850.